Key result
Wearable-derived minimum heart rate links to ~321% higher metabolic syndrome risk per 10-bpm increase in men.
Why the study?
Early detection of metabolic syndrome enables timely interventions, but the association between metabolic syndrome and wearable-measured heart rate compared to clinical resting heart rate in real-world settings needed investigation.
Does continuous heart rate monitoring using commercial wearable fitness trackers identify the presence of pre-metabolic or metabolic syndrome in middle-aged adults?
Observational (n=564)
Does continuous heart rate monitoring using commercial wearable fitness trackers identify the presence of pre-metabolic or metabolic syndrome in middle-aged adults?
Effect estimate: OR 4.21 (95% CI 1.87-10.47)
Hypothesis-generating for wearable HR in metabolic syndrome detection; prospective validation required before clinical adoption.
Metabolic syndrome increases the risks of cardiovascular diseases, type 2 diabetes, and certain cancers. The early detection of metabolic syndrome is clinically relevant, as it enables timely and targeted interventions. In the current study, we aimed to investigate the association between metabolic syndrome and heart rate measured using wearable devices in a real-world setting and compare this association with that for clinical resting heart rate. Data from 564 middle-aged adults who wore wearable devices for at least 7 days with a minimum daily wear time of 20 h were analyzed. The results showed significantly elevated all-day, sleeping, minimum, and inactive heart rates in men with pre-metabolic or metabolic syndrome compared with those in normal individuals, whereas sleeping heart rate and heart rate dips were significantly increased and decreased, respectively, in women with metabolic syndrome. After adjusting for confounders, every 10-beats-per-minute increment in all-day, sleeping, minimum, and inactive heart rates in men corresponded to odds ratios of 2.80 (95% confidence interval 1.53-5.44), 3.06 (1.57-6.40), 4.21 (1.87-10.47), and 3.09 (1.64-6.29), respectively, for the presence of pre-metabolic or metabolic syndrome. In women, the association was significant only for heart rate dips (odds ratio = 0.49 [95% confidence interval 0.25-0.96] for every 10% increment). Models incorporating inactive or minimum heart rate in men and heart rate dip in women demonstrated better fits, as indicated by lower Akaike information criterion values (170.3 in men and 364.9 in women), compared with models that included clinical resting heart rate (173.4 in men and 369.1 in women). These findings suggest that the heart rate indices obtained from wearable devices may facilitate early identification of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Mun et al. (2024) conducted an observational in Metabolic syndrome (n=564). Wearable fitness trackers (heart rate measurements) vs. Clinical resting heart rate was evaluated on Presence of pre-metabolic or metabolic syndrome (OR 4.21, 95% CI 1.87-10.47). Wearable device-derived minimum heart rate in men (OR 4.21; 95% CI 1.87-10.47 per 10-bpm increase) and heart rate dips in women were significantly associated with metabolic syndrome risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: